Synopsys (SNPS)
(Delayed Data from NSDQ)
$621.30 USD
+14.31 (2.36%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $620.35 -0.95 (-0.15%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SNPS 621.30 +14.31(2.36%)
Will SNPS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SNPS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNPS
Top Stock Reports for Applied Materials, Comcast & Synopsys
Why Is Salesforce.com (CRM) Up 16% Since Last Earnings Report?
SNPS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Synopsys (SNPS) Stock Sinks As Market Gains: What You Should Know
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
Synopsys (SNPS) Expands Its AI-based Multi-Die Portfolio
Other News for SNPS
Decoding 7 Analyst Evaluations For Synopsys
Synopsys price target raised by $15 at KeyBanc, here's why
Cadence Design price target raised by $5 at KeyBanc, here's why
Wells Fargo updated its Signature Picks, with Vertex Pharma and AvalonBay as adds
Synopsys, Cadence Design likely to benefit as chip design gets tougher: Baird